Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Prolonged Dual Antiplatelet Therapy in ST-Segment Elevation vs. Non-ST-Segment Elevation Myocardial Infarction.
Kim J, Song YB, Oh JH, Cho DK, Lee JB, Kim SH, Jeong JO, Bae JH, Kim BO, Cho JH, Suh IW, Kim DI, Park HK, Park JS, Choi WG, Lee WS, Choi KH, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Gwon HC, Doh JH, Hahn JY; SMART-DATE Investigators. Kim J, et al. Circ J. 2021 May 25;85(6):817-825. doi: 10.1253/circj.CJ-20-0704. Epub 2021 Jan 9. Circ J. 2021. PMID: 33431720 Free article.
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention.
Lee SH, Kim HK, Jeong MH, Yasuda S, Honda S, Jeong YH, Lee JM, Hahn JY, Kang J, Chae SC, Seong IW, Park JS, Chae JK, Hur SH, Cha KS, Kim HS, Seung KB, Rha SW, Hwang JY, Choi DJ, Oh SK, Kim SS, Park TK, Yang JH, Song YB, Choi SH, Gwon HC; KAMIR, JAMIR, and SMART-DATE Investigators. Lee SH, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):112-124. doi: 10.1093/ehjcvp/pvaa005. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 31977008
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
Hahn JY, Song YB, Oh JH, Cho DK, Lee JB, Doh JH, Kim SH, Jeong JO, Bae JH, Kim BO, Cho JH, Suh IW, Kim DI, Park HK, Park JS, Choi WG, Lee WS, Kim J, Choi KH, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Gwon HC; SMART-DATE investigators. Hahn JY, et al. Lancet. 2018 Mar 31;391(10127):1274-1284. doi: 10.1016/S0140-6736(18)30493-8. Epub 2018 Mar 12. Lancet. 2018. PMID: 29544699 Clinical Trial.